UnitedHealth stock drops 17% after reported – Business News
UnitedHealth Group’s stock plunged Thursday morning after a report that the embattled insurance coverage giant was being probed for Medicare fraud.
The Department of Justice has been conducting the prison investigation into whether or not the company — which pushed out CEO Andrew Witty on Monday — manipulated Medicare Advantage billing practices to improperly increase federal funds by inflating affected person risk scores, the Wall Street Journal reported on Wednesday.
The existence of the probe, which started final 12 months however had not been beforehand disclosed, despatched shares of UnitedHealth plummeting 17% after the opening bell. Shares have fallen more than 50% prior to now month.
The Justice Department has been conducting a prison investigation into UnitedHealth Group, in line with a report. AP
The investigation is being overseen by the DOJ’s prison healthcare fraud unit, with prosecutors primarily based in New York main the inquiry, sources advised the Journal.
UnitedHealth, which was rocked final 12 months by the execution-style killing of prime government Brian Thompson, mentioned it had not been notified of the investigation.
“We stand by the integrity of our Medicare Advantage program,” a spokesperson mentioned in a assertion.
The Justice Department declined to remark. The Post has sought remark from UnitedHealth.
The revelation provides to mounting scrutiny of the company, which was already going through civil and antitrust investigations.
In addition to the CEO shake-up, UnitedHealth has been coping with the fallout of a cyberattack that disrupted funds to suppliers nationwide and Thompson’s killing.
The Justice Department investigation has reportedly been specializing in doable Medicare fraud associated to its Medicare Advantage operations. Christopher Sadowski
Last December, the CEO of UnitedHealthcare, a subsidiary which sells health insurance coverage, was gunned down in Manhattan by alleged murderer Luigi Mangione.
In February, the Journal reported that UnitedHealth was beneath civil investigation for probably fraudulent Medicare billing practices at its Optum division.
At the time, the company dismissed the story as “misinformation” and mentioned it was unaware of any new probes.
However, an inside March 11 e-mail from a UnitedHealth legal professional, disclosed in a shareholder lawsuit, acknowledged that “the government has asked us some questions regarding Optum’s coding practices,” describing the inquiry as “in the early stages.”
The DOJ’s healthcare fraud unit, which historically targeted on overbilling by suppliers, has in recent times shifted consideration to insurance coverage firms administering Medicare Advantage plans.
News of the investigation despatched the company’s stock price plummeting by more than 17%. Google Finance
These insurers are paid more for overlaying sufferers with more extreme situations, creating an incentive to report in depth diagnoses –typically dubiously.
UnitedHealth has pushed back towards allegations that it submitted inflated or unsupported diagnoses, calling such claims “inaccurate and biased.”
The company argues that Medicare Advantage delivers superior outcomes and decrease prices than conventional Medicare.
The company’s most up-to-date SEC submitting notes ongoing governmental audits and investigations however doesn’t explicitly point out the prison, civil or antitrust probes now underway.
UnitedHealth additionally faces a civil whistleblower lawsuit accusing it of submitting $2 billion value of diagnoses that inside audits discovered weren’t backed by medical information.
While a court-appointed particular grasp lately beneficial dismissing the case resulting from inadequate proof, the DOJ has urged the decide to reject that suggestion.
UnitedHealth countered that the discovering exhibits “there was no evidence to support the DOJ’s claims we were overpaid or that we did anything wrong.”
